Jitka Krizkova - Inst Hematol & Blood Transfus

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Somatic Mutations and Outcomes in CML Adolescent and Young Adults Compared to Children, Adults, and BCR::ABL1-positive ALL Patients

Katerina Machova Polakova,Jitka Krizkova,Vaclava Polivkova, Adam Laznicka,Nikola Curik,Adela Benesova, Pavla Suchankova, Tomas Smazik, Veronika Vysinova,Dana Mikulenkova,Hana Klamova,Marketa Stastna Markova, Dana Srb,Jan Zuna,Marketa Zaliova,Jan Trka,Cyril Salek

crossref（2025）

引用0浏览0引用

Blinatumomab in Induction Therapy Improves Molecular Response in Untreated Adults with Ph- B-cell Precursor Acute Lymphoblastic Leukemia

Cyril Salek,Stepan Hrabovsky,Frantisek Folber, Zdenek Koristek,Jan M Horacek,Eva Fronkova,Leona Rezkova Reznickova,Pavla Pecherkova, Petr Soukup, Barbora Dluhosova,Vaclava Polivkova,Jitka Krizkova,Katerina Machova Polakova,Zuzana Vrzalova, Hana Halamova,Jan Trka, Petr Cetkovsky, Michael Doubek

Haematologica (2025)

引用0浏览0WOS引用

Unstable Major Molecular Response As a Trigger for Next Generation Sequencing‐based BCR::ABL1 Mutation Testing in Chronic Myeloid Leukemia

Adela Benesova,Sara De Santis,Václava Polívková,Pavla Pecherková,Jitka Křížková, Pavla Suchánková,Cecilia Monaldi,Hana Klamová,Dana Srbová,Hana Žižková,Andreas Hochhaus,Simona Soverini,Kateřina Machová Poláková

American journal of hematologyno. 4 (2024): 759-762

引用0浏览0引用

Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia

Adela Benesova,Sara De Santis,Vaclava Polivkova,Pavla Pecherkova,Jitka Krizkova, Pavla Suchankova,Cecilia Monaldi,Hana Klamova,Dana Srbova,Hana Zizkova,Andreas Hochhaus,Simona Soverini,Katerina Machova Polakova

American journal of hematologyno. 4 (2024): 759-762

引用0浏览0WOS引用

Imatinib Therapy of Chronic Myeloid Leukemia Significantly Reduces Carnitine Cell Intake, Resulting in Adverse Events

Pavel Burda,Alzbeta Hlavackova, Vendula Polivkova,Nikola Curik, Adam Laznicka,Jitka Krizkova,Jiri Suttnar,Pavel Klener,Katerina Machova Polakova

Molecular Metabolism（2024）

引用0浏览0WOS引用

Unstable Major Molecular Response As a Trigger for Next Generation Sequencing‐based BCR::ABL1 Mutation Testing in Chronic Myeloid Leukemia

American Journal of Hematology（2024）

引用0浏览0引用

Combination Therapies with Ponatinib and Asciminib in a Preclinical Model of Chronic Myeloid Leukemia Blast Crisis with Compound Mutations

Nikola Curik,Adam Laznicka,Vaclava Polivkova,Jitka Krizkova,Eva Pokorna,Pavel Semerak, Pavla Suchankova,Pavel Burda,Andreas Hochhaus,Katerina Machova Polakova

Leukemiano. 6 (2024): 1415-1418

引用0浏览0WOSNATURE引用

S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL

Nikola Čuřík,Adam Laznicka,Vaclava Polivkova,Jitka Křížková,Pavel Semerak,Eva Pokorna, Pavla Suchankova,Pavel Burda,Andreas Hochhaus,Kateřina Machová Poláková

HemaSphereno. S3 (2023)

引用0浏览0引用

Somatic Mutations in Cancer-Related Genes Were Observed More Frequently in AYA CML Patients Compared to Elderly at Diagnosis, Whereas the Frequency Was Markedly Higher in Elderly Patients During TKI Treatment

Jitka Krizkova,Vaclava Polivkova,Nikola Curik,Adam Laznicka,Adela Benesova,Hana Klamova,Marketa Stastna Markova,Dana Srbova,Jan Zuna,Marketa Zaliova,Jan Trka,Pavel Semerak,Tomas Kalina,Cyril Salek,Katerina Machova Polakova

Blood（2023）

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn